Ignite Creation Date:
2025-12-25 @ 4:20 AM
Ignite Modification Date:
2025-12-26 @ 3:21 AM
Study NCT ID:
NCT04999020
Status:
TERMINATED
Last Update Posted:
2025-07-09
First Post:
2021-08-04
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Ravulizumab Versus Placebo in Adult Participants With Dermatomyositis
Sponsor:
Alexion Pharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-11-19
Start Date Type:
ACTUAL
Primary Completion Date:
2023-10-26
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-05-08
Completion Date Type:
ACTUAL
First Submit Date:
2021-08-04
First Submit QC Date:
None
Study First Post Date:
2021-08-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-10-15
Results First Submit QC Date:
None
Results First Post Date:
2024-12-06
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-07-07
Last Update Post Date:
2025-07-09
Last Update Post Date Type:
ACTUAL